SCHEMBL27736360

SCHEMBL27736360

Fc1cccc(COc2ccc(Nc3ncnc4ccc(-c5c[nH]c(NC6CCNCC6)c5)cc34)cc2Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.64
ERBB2 P04626 16/20 0.64
ABL1 P00519 4/20 0.60
INSR P06213 4/20 0.60
PDGFRB P09619 4/20 0.60
CDK2 P24941 4/20 0.60
PLK1 P53350 4/20 0.60
HDAC1 Q13547 4/20 0.60
HDAC8 Q9BY41 4/20 0.60
HDAC6 Q9UBN7 4/20 0.60
HDAC3 O15379 3/20 0.59
HDAC4 P56524 3/20 0.59
HDAC7 Q8WUI4 3/20 0.59
HDAC2 Q92769 3/20 0.59
HDAC10 Q969S8 3/20 0.59
HDAC11 Q96DB2 3/20 0.59
HDAC9 Q9UKV0 3/20 0.59
HDAC5 Q9UQL6 3/20 0.59
GAK O14976 1/20 0.56
ERBB4 Q15303 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27736411 0.84 EGFR (0.67) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL27756937 0.84 ERBB2 (0.62) EGFRERBB2ABL1INSRPDGFRB
Tert-Butyl Formate SCHEMBL27736479 0.83 EGFR (0.55) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL27736376 0.82 EGFR (0.67) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL5567988 0.82 EGFR (0.69) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL27736483 0.81 EGFR (0.68) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL17083347 0.81 EGFR (0.74) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL27736471 0.81 EGFR (0.68) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL17075806 0.81 EGFR (0.75) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL20365436 0.80 EGFR (0.72) EGFRERBB2ABL1INSRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101367794-B Preparation method for quinazoline derivants and medical uses thereof SHANGHAI HENGRUI PHARM CO LTD 2013-07-10 CN disclosed
CN-101367794-A Preparation method for quinazoline derivants and medical uses thereof SHANGHAI HENGRUI PHARM CO LTD (CN) 2009-02-18 CN disclosed